.

Avrobio Inc reported $-28054000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Applied Genetic Technologies AGTC:US $ -18.39M 4.09M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Epizyme EPZM:US $ -35.74M 19.76M
Gilead Sciences GILD:US $ 1144M 1125M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Macrogenics MGNX:US $ -41.3M 25.14M
Pfizer PFE:US $ 9905M 2042M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Takeda 4502:JP Y 105014M 116372M